From: Radiomics in medical imaging—“how-to” guide and critical reflection
Ref. | Study (first author) | Year | Factor | Site/Organ | |
---|---|---|---|---|---|
Test-retest | [77] | Konert et al. | 2020 | NSCLC | |
[78] | Vuong et al. | 2019 | Lung cancer | ||
[79] | Gallivanone et al. | 2018 | Phantom | ||
[40] | Desseroit et al. | 2017 | NSCLC | ||
[80] | Leijenaar et al. | 2013 | NSCLC | ||
Acquisition | [77] | Konert et al. | 2020 | Breathing | NSCLC |
[81] | Pfaehler et al. | 2019 | Acquisition time | Phantom | |
[82] | Branchini et al. | 2019 | Injected activity | Pedriatic cancer | |
[78] | Vuong et al. | 2019 | Breathing | Lung cancer | |
[83] | Charles et al. | 2017 | Breathing | Phantom | |
[84] | Lovat et al. | 2017 | Scan timing | Neurofibromatosis-1 | |
[85] | Reuzé et al. | 2017 | Scanner | Cervical cancer | |
[86] | Shiri et al. | 2017 | Acquisition time | Phantom, lung, HN, liver cancer | |
[13] | Bailly et al. | 2016 | Acquisition time | Neuroendocrine tumors | |
[87] | Forgacs et al. | 2016 | Acquisition time | Phantom, lung cancer | |
[88] | Grootjans et al. | 2016 | Breathing, duty cycle | Lung cancer | |
[89] | Nyflot et al. | 2015 | Injected activity, acquisiton time | Simulated phantom | |
Reconstruction | [81] | Pfaehler et al. | 2019 | Algorithm, PSF, FWHM | Phantom |
[79] | Gallivanone et al. | 2018 | PSF, TOF, matrix size, iterations, subsets, FWHM | Phantom | |
[12] | Altazi et al. | 2017 | Algorithm | Cervical tumor | |
[86] | Shiri et al. | 2017 | PSF, TOF, iterations, subsets, FWHM, matrix size | Phantom, lung, HN, liver cancer | |
[13] | Bailly et al. | 2016 | Algorithm, iterations, FWHM, matrix size | Neuroendocrine tumors | |
[90] | Cheng et al. | 2016 | Attenuation correction | NSCLC | |
[87] | Forgacs et al. | 2016 | Algorithm, TOF, FWHM, voxel size | Phantom, lung cancer | |
[91] | Lasnon et al. | 2016 | PSF, FWHM | Lung cancer | |
[92] | van Velden et al. | 2016 | Algorithm | NSCLC | |
[93] | Doumou et al. | 2015 | FWHM | Esophageal cancer | |
[89] | Nyflot et al. | 2015 | Iterations, FWHM | Phantom | |
[94] | Yan et al. | 2015 | PSF, TOF, iterations, FWHM, matrix size | Lung cancer | |
Segmentation | [77] | Konert et al. | 2020 | NSCLC | |
[95] | Yang et al. | 2020 | Simulated lung lesions | ||
[81] | Pfaehler et al. | 2019 | Phantom | ||
[78] | Vuong et al. | 2019 | Lung cancer | ||
[79] | Gallivanone et al. | 2018 | Phantom | ||
[96] | Hatt et al. | 2018 | NSCLC, HN, simulated lesions | ||
[12] | Altazi et al. | 2017 | Cervical tumor | ||
[83] | Charles et al. | 2017 | Phantom | ||
[97] | Lu et al. | 2016 | Nasopharyngeal carcinoma | ||
[92] | van Velden et al. | 2016 | NSCLC | ||
[93] | Doumou et al. | 2015 | Esophageal cancer | ||
[98] | Hatt et al. | 2013 | Esophageal cancer | ||
[80] | Leijenaar et al. | 2013 | NSCLC | ||
Image processing | [77] | Konert et al. | 2020 | Discretization | NSCLC |
[95] | Yang et al. | 2020 | Discretization | Simulated lung lesions | |
[82] | Branchini et al. | 2019 | Discretization | Pedriatic cancer | |
[87] | Forgacs et al. | 2019 | Discretization | Lung cancer | |
[81] | Pfaehler et al. | 2019 | Discretization | Phantom | |
[99] | Whybra et al. | 2019 | Resampling | Esophageal cancer | |
[100] | Presotto et al. | 2018 | Discretization | Phantom | |
[12] | Altazi et al. | 2017 | Discretization | Cervical cancer | |
[85] | Reuzé et al. | 2017 | Resampling | Cervical cancer | |
[101] | Yip et al. | 2017 | Discretization, resampling | NSCLC | |
[97] | Lu et al. | 2016 | Discretization | Nasopharyngeal carcinoma | |
[92] | van Velden et al. | 2016 | Discretization | NSCLC | |
[93] | Doumou et al. | 2015 | Discretization | Esophageal cancer | |
[14] | Leijenaar et al. | 2015 | Discretization | NSCLC |